EUVIMEDEUVIMED entdecken
Crossref

Discovery of chalcone-quinazolinone hybrids as BRAF kinase inhibitors with potential anticancer activity: Design, synthesis, biological evaluation, and molecular modeling studies

Randa Atef Ibrahim Abdelaziz, Iman Ahmed Youssef Ghannam, Heba Abdelrasheed Allam, Ahmed Mahmoud El Kerdawy, Rasha Mousa Allam, Mahmoud Taha Abo-Elfadl, Safinaz El-Sayed Abbas

Bioorganic Chemistry · 2026-11 · 184 · 110709

DOI: 10.1016/j.bioorg.2026.110709 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Bioorganic Chemistry, 2026-11. Verfasst von Randa Atef Ibrahim Abdelaziz und 6 weiteren Autor:innen. Beteiligte Einrichtung: Postgraduate Program in Pharmaceutical Chemistry, Faculty of Pharmacy, Cairo University, Kasr El-Aini Street, Cairo, P.O. Box, 11562, Egypt; Egyptian…. Hauptthemen laut MEDLINE: Proto-Oncogene Proteins B-raf, Antineoplastic Agents, Protein Kinase Inhibitors, Drug Design. Die Arbeit nennt 49 Literaturangaben. Gefördert von: STDF.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BRAF has emerged as an important target for inhibiting tumor cell proliferation. Accordingly, some chalcone-quinazolinone conjugates 4a-l were designed, synthesized and screened for their BRAF inhibitory activity. Compounds 4d, 4f, and 4l that revealed the most potent BRAFWT inhibition (IC50 = 0.572, 0.482, and 0.317 μM, respectively), in comparison to sorafenib (IC50 = 0.132 μM), were further tested for their efficacy on mutant BRAFV600E, where they showed promising inhibition (IC50 = 0.105, 0.067, and 0.275 μM, respectively), relative to vemurafenib (IC50 = 0.063 μM). The cytotoxic potential of 4d, 4f, and 4l demonstrated the selectivity of 4d and 4f towards HT-29 cancer cell line expressing BRAFV600E. Therefore, 4l was further evaluated for its inhibitory activity on EGFR, where it demonstrated potent inhibition with IC50 = 0.098 μM compared to gefitinib (IC50 = 0.037 μM). Moreover, 4f caused a cell cycle arrest at S and G2/M phases in HT-29 cells besides apoptotic induction. Potential biomarkers of apoptosis revealed the effectiveness of 4f in increasing Bax/Bcl-2 ratio by 19-fold, and upregulation of expression of Caspase-3 and Caspase-9 by 6- and 8-fold, respectively, relative to control HT-29 cancer cells. Molecular docking studies and molecular dynamics simulations were performed to correlate the biological activity of the newly synthesized compounds with their binding modes and investigate the dynamic stability of the 4f/BRAF complex.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Proto-Oncogene Proteins B-rafAntineoplastic AgentsProtein Kinase InhibitorsDrug DesignQuinazolinonesChalconeDrug DiscoveryHumansCell ProliferationDrug Screening Assays, AntitumorStructure-Activity RelationshipMolecular StructureApoptosisDose-Response Relationship, DrugMolecular Docking SimulationModels, Molecular

Stichwörter der Autor:innen

Anticancer activityBRAFChalconeMolecular dockingMolecular dynamics simulationsQuinazolinone

Substanzen

Proto-Oncogene Proteins B-rafAntineoplastic AgentsProtein Kinase InhibitorsQuinazolinonesBRAF protein, humanChalcone

Autor:innen und Institutionen

  • Postgraduate Program in Pharmaceutical Chemistry, Faculty of Pharmacy, Cairo University, Kasr El-Aini Street, Cairo, P.O. Box, 11562, Egypt; Egyptian Intellectual Property Authority (EGIPA), Cairo, Egypt.
  • Chemistry of Natural and Microbial Products Department, Pharmaceutical and Drug Industries Research Institute, National Research Centre, Dokki, Cairo 12622, Egypt. Electronic address: iman.youssef.ghannam@gmail.com.
  • Department of Pharmaceutical Chemistry, Faculty of Pharmacy, Cairo University, Kasr El-Aini Street, Cairo, P.O. Box, 11562, Egypt. Electronic address: Heba.abdelkhalek@pharma.cu.edu.eg.
  • Department of Pharmaceutical Chemistry, Faculty of Pharmacy, Cairo University, Kasr El-Aini Street, Cairo, P.O. Box, 11562, Egypt; Lincoln Medical School, College of Health and Science, University of Lincoln, Lincoln, U…
  • Pharmacology Department, Medical Research and Clinical Studies Institute, National Research Centre, Dokki, Cairo 12622, Egypt.
  • Cancer Biology and Genetics Laboratory, Centre of Excellence for Advanced Sciences, National Research Centre, Dokki, Cairo 12622, Egypt; Biochemistry Department, Biotechnology Research Institute, National Research Centr…

Förderung

  • STDF

Zitieren

APA

Abdelaziz, R. A. I., Ghannam, I. A. Y., Allam, H. A., El Kerdawy, A. M., Allam, R. M., Abo-Elfadl, M. T., & Abbas, S. E. (2026). Discovery of chalcone-quinazolinone hybrids as BRAF kinase inhibitors with potential anticancer activity: Design, synthesis, biological evaluation, and molecular modeling studies. Bioorganic Chemistry, 184, 110709. https://doi.org/10.1016/j.bioorg.2026.110709

Vancouver

Abdelaziz RAI, Ghannam IAY, Allam HA, El Kerdawy AM, Allam RM, Abo-Elfadl MT, et al. Discovery of chalcone-quinazolinone hybrids as BRAF kinase inhibitors with potential anticancer activity: Design, synthesis, biological evaluation, and molecular modeling studies. Bioorganic Chemistry. 2026;184:110709. doi:10.1016/j.bioorg.2026.110709

BibTeX
@article{Abdelaziz2026,
  author = {Abdelaziz, Randa Atef Ibrahim and Ghannam, Iman Ahmed Youssef and Allam, Heba Abdelrasheed and El Kerdawy, Ahmed Mahmoud and Allam, Rasha Mousa and Abo-Elfadl, Mahmoud Taha and Abbas, Safinaz El-Sayed},
  title = {Discovery of chalcone-quinazolinone hybrids as BRAF kinase inhibitors with potential anticancer activity: Design, synthesis, biological evaluation, and molecular modeling studies},
  journal = {Bioorganic Chemistry},
  year = {2026},
  volume = {184},
  pages = {110709},
  doi = {10.1016/j.bioorg.2026.110709}
}
Kostenlos starten →